Raising market visibility of a medtech company
Robocath unveils survey findings on users’ current expectations and future developments
©Lowres
Carthera receives Orphan Drug Designation from US and EU authorities for carboplatin in malignant glioma
© Carthera
Ciliatech’s glaucoma implant CID receives favorable opinion on treating both open and narrow angle forms of disease
© Ciliatech
Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma
©Carthera
Endostart receives FDA 510(k) clearance for Endorail®, ushering in new era of gastrointestinal endoscopy innovation
© Endostart
RDS secures CE mark for MultiSense® Remote Patient Monitoring solution
Carthera enrolls first patient in pivotal trial of SonoCloud-9® device for treatment of recurrent glioblastoma
©Carthera
VIVES IUF Fund secures €70 million equity
© David Plas
RDS welcomes MACSF as investor to help drive transformation of patient pathway
©RDS